The earnings call reflects a solid performance in the first half of 2025 with strong organic sales growth and improved EBITDA margins. However, challenges such as currency headwinds and softness in the Beverages segment present some concerns. The company's positive outlook and strategic plans for future growth contribute to a balanced sentiment.

Company Guidance

During the Novonesis Conference Call on August 21, 2025, the company provided guidance for the full year, forecasting organic sales growth of 6% to 8%, revised from a previous range of 5% to 8%. This guidance was based on strong first-half performance, which included 9% organic sales growth, with volumes up by 8% and prices up by 1%. Emerging markets exhibited robust growth at 12%, while developed markets grew by 8%. The adjusted EBITDA margin for the first half was 37.4%, bolstered by a 2.1 percentage point increase compared to the previous year, despite adverse currency impacts. The company's strategic initiatives also included the successful integration of the Feed Enzymes Alliance acquisition and achieving a 100% run rate in cost synergies one year ahead of schedule. The company maintained its expected adjusted EBITDA margin of 37% to 38% for the year.

Strong Organic Sales Growth

Novonesis achieved a 9% organic sales growth in the first half of 2025, with a volume increase of 8% and a pricing contribution of 1%. Emerging markets showed a particularly strong growth of 12%.

Adjusted EBITDA Margin Improvement

The adjusted EBITDA margin increased by 2.1 percentage points to 37.4% for the first half of the year despite weaker currencies.

Food & Health Biosolutions Performance

The division delivered a 10% organic sales growth in the first half of the year with an adjusted EBITDA margin increase of 2.1 percentage points.

Household Care Growth

Household Care achieved 8% organic sales growth in the first half of 2025, driven mainly by volume growth and solid performance in emerging markets.

2025 Outlook Upgraded

The company upgraded its full-year organic sales growth guidance to 6% to 8%, up from the previous 5% to 8%.

Novonesis (NVZMY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

NVZMY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2025	2025 (Q3)	0.66 / -	0.377	―	―	―
Aug 21, 2025	2025 (Q2)	0.67 / 0.42	0.69	-39.42% (-0.27)
May 08, 2025	2025 (Q1)	0.44 / 0.47	0.536	-11.57% (-0.06)
Feb 26, 2025	2024 (Q4)	0.54 / 0.67	0.365	84.11% (+0.31)
Nov 07, 2024	2024 (Q3)	0.57 / -	0.476	―
Aug 27, 2024	2024 (Q2)	0.65 / 0.69	0.321	114.95% (+0.37)
May 03, 2024	2024 (Q1)	0.58 / 0.90	0.418	114.83% (+0.48)
Feb 01, 2024	2023 (Q4)	0.47 / 0.36	0.464	-21.34% (-0.10)
Oct 26, 2023	2023 (Q3)	0.41 / 0.48	0.543	-12.34% (-0.07)
Aug 09, 2023	2023 (Q2)	0.41 / 0.32	0.403	-20.35% (-0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

NVZMY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 21, 2025	$65.49	$60.69	-7.33%
May 08, 2025	$64.86	$67.16	+3.55%
Feb 26, 2025	$56.66	$59.93	+5.77%
Nov 07, 2024	$58.36	$61.08	+4.66%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Novonesis (NVZMY) report earnings?

Novonesis (NVZMY) is schdueled to report earning on Nov 06, 2025, Before Open (Confirmed).

What is Novonesis (NVZMY) earnings time?

Novonesis (NVZMY) earnings time is at Nov 06, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is NVZMY EPS forecast?

NVZMY EPS forecast for the fiscal quarter 2025 (Q3) is 0.66.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing